top of page
Image-empty-state.png

Evelina Tacconelli

Director

Email:

Phone:

+39 045 812 8243

Short biography

Evelina Tacconelli is a Full Professor of Infectious Diseases at the University of Verona, Italy and Head of the DZIF Clinical Research Unit on healthcare associated infections and antimicrobial resistance at the Tübingen University, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO, ECDC and EMA on antimicrobial resistance and infection control. Her main areas of scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. Co-coordinator of the Unit of research on healthcare-associated and antibiotic-resistant bacterial infections (TTU-HAARBI) within the German Center for Infectious Diseases (DZIF). She is the ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology. Member of the SAB of the JPI-AMR. Chair of the 2018 WHO Priority List of Pathogens for R&D of new antibiotics. Chair of the European Committee of Infection Control (EUCIC). Chair of the ESCMID guidelines on prevention and therapy of infections due to multidrug-resistant Gram negative bacteria (MDR-GN) and EUCIC guideline on decolonization procedures for patients colonized with MDR-GN. Involved (partner site or coordinator) in many European studies on prevention and therapy of infections caused by antibiotic-resistant bacteria financed by European Commission, WHO, JPI-AMR, Horizon2020, DG-Sanco, IMI, and DZIF. She serves on the International Advisory Board of Lancet Infectious Diseases, Editorial Board of Journal of Antimicrobial Chemotherapy and Scientific Committee of Clinical Microbiology and Infection. Author and co-author of more than 200 papers listed in SCI-JCR and NIH Medline. In April 2023 Evelina was appointed as Chief Scientific Officer (CSO) of the Ecraid Foundation.

Projects

ECRAID-Base

EU-RESPONSE

ENACT-SOS COVID

COMBACTE-NET-EXPECT

VACCELERATE

AMR Travel Tool

EPI-Net

ENACT-REACT COVID (microbiome signatures)

Chemsex MSM

COHERENCE

MPX-RESPONSE

PRIMAVERA

ORCHESTRA

VALUE-DX

ENACT-REACT COVID (long term follow up)

ARCH-NET

WHO BPPL

Sentinella

Excellence Centres

SOLIDARITY-Italy

ENACT-REACT COVID (risk assessment)

Publications

27/6/24

Medical Mycology

Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List

4/5/24


International Journal of Infectious Diseases

SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV

27/6/24

Medical Mycology

Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List

3/5/24

Viruses

Exploring Viral Genome Profile in Mpox Patients during the 2022 Outbreak, in a North-Eastern Centre of Italy

17/6/24

Medical Mycology

Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list

30/4/24

Infection

Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group

bottom of page